Velan Capital Investment Management LP Heron Therapeutics, Inc. Transaction History
Velan Capital Investment Management LP
- $58 Million
- Q1 2025
A detailed history of Velan Capital Investment Management LP transactions in Heron Therapeutics, Inc. stock. As of the latest transaction made, Velan Capital Investment Management LP holds 6,986,744 shares of HRTX stock, worth $13.3 Million. This represents 26.51% of its overall portfolio holdings.
Number of Shares
6,986,744
Previous 6,986,744
-0.0%
Holding current value
$13.3 Million
Previous $10.7 Million
43.79%
% of portfolio
26.51%
Previous 22.07%
Shares
3 transactions
Others Institutions Holding HRTX
# of Institutions
183Shares Held
125MCall Options Held
847KPut Options Held
47.7K-
Rubric Capital Management LP New York, NY26.7MShares$50.8 Million1.68% of portfolio
-
Black Rock Inc. New York, NY8.33MShares$15.8 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.23MShares$15.6 Million0.0% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA7.85MShares$14.9 Million0.03% of portfolio
-
Palisade Capital Management LLC Fort Lee, NJ5.29MShares$10 Million0.41% of portfolio
About HERON THERAPEUTICS, INC.
- Ticker HRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 118,774,000
- Market Cap $226M
- Description
- Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...